Low serum vitamin D levels in Iranians with immune thrombocytopenia: A single-center study

Background & Aims:  Immune thrombocytopenia is a disorder characterized by decreased platelet production and degradation. The objectives of our study were to assess the relationship between 1,25(OH)2D3 levels and ITP based on sex, age, and duration of disease. Materials & Methods: The presen...

Full description

Bibliographic Details
Main Authors: Mahsa Matinkia, Rahim Asghari, Hamdollah Sharifi
Format: Article
Language:English
Published: Urmia University of Medical Sciences 2021-11-01
Series:Journal of Research in Applied and Basic Medical Sciences
Subjects:
Online Access:http://ijrabms.umsu.ac.ir/article-1-96-en.pdf
_version_ 1797743282848006144
author Mahsa Matinkia
Rahim Asghari
Hamdollah Sharifi
author_facet Mahsa Matinkia
Rahim Asghari
Hamdollah Sharifi
author_sort Mahsa Matinkia
collection DOAJ
description Background & Aims:  Immune thrombocytopenia is a disorder characterized by decreased platelet production and degradation. The objectives of our study were to assess the relationship between 1,25(OH)2D3 levels and ITP based on sex, age, and duration of disease. Materials & Methods: The present study was retrospectively conducted by reviewing medical records of the ITP patients. Demographic data including age, sex, disease history and serum vitamin D levels were performed and collected in a pre-designed form. Data were reported as Mean ±SD and as frequency (percentage). Independent t-test or ANOVA tests were used to compare the mean serum levels of vitamin D in terms of sex, age or disease history. Results: A total of 140 subjects (71 females and 69 males) with mean age± SD of 39.90 ± 16.11 years enrolled in the study. The mean serum vitamin D level in patients was 18.85 ± 10.87. There was no significant relationship between sex and serum vitamin D level (P=0.943). Patients in the range of 30-40 years have the most frequency and the lowest level of vitamin D in serum (17.11± 9.68 ng/ml). There was no association between age and vitamin D based on Pearson’s test (p=0.181). Vitamin D level in acute ITP patients was lower than chronic ITP patients, but this difference was not meaningful (p=0.403). Conclusion: According to the findings of this study vitamin D can be administered as a new immunomodulatory therapy in patients with ITP.
first_indexed 2024-03-12T14:54:16Z
format Article
id doaj.art-02a89bc840ea40fb8df11120e870cf63
institution Directory Open Access Journal
issn 2717-0098
language English
last_indexed 2024-03-12T14:54:16Z
publishDate 2021-11-01
publisher Urmia University of Medical Sciences
record_format Article
series Journal of Research in Applied and Basic Medical Sciences
spelling doaj.art-02a89bc840ea40fb8df11120e870cf632023-08-15T04:52:27ZengUrmia University of Medical SciencesJournal of Research in Applied and Basic Medical Sciences2717-00982021-11-0172100103Low serum vitamin D levels in Iranians with immune thrombocytopenia: A single-center studyMahsa Matinkia0Rahim Asghari1Hamdollah Sharifi2 Department of internal medicine, Faculty of Medicine, Urmia University of Medical Sciences, Urmia-Iran. Department of internal medicine, Faculty of Medicine, Urmia University of Medical Sciences, Urmia-Iran. Department of Pharmacology, Pharmacy Faculty, Urmia University of Medical Sciences, Urmia- Iran Background & Aims:  Immune thrombocytopenia is a disorder characterized by decreased platelet production and degradation. The objectives of our study were to assess the relationship between 1,25(OH)2D3 levels and ITP based on sex, age, and duration of disease. Materials & Methods: The present study was retrospectively conducted by reviewing medical records of the ITP patients. Demographic data including age, sex, disease history and serum vitamin D levels were performed and collected in a pre-designed form. Data were reported as Mean ±SD and as frequency (percentage). Independent t-test or ANOVA tests were used to compare the mean serum levels of vitamin D in terms of sex, age or disease history. Results: A total of 140 subjects (71 females and 69 males) with mean age± SD of 39.90 ± 16.11 years enrolled in the study. The mean serum vitamin D level in patients was 18.85 ± 10.87. There was no significant relationship between sex and serum vitamin D level (P=0.943). Patients in the range of 30-40 years have the most frequency and the lowest level of vitamin D in serum (17.11± 9.68 ng/ml). There was no association between age and vitamin D based on Pearson’s test (p=0.181). Vitamin D level in acute ITP patients was lower than chronic ITP patients, but this difference was not meaningful (p=0.403). Conclusion: According to the findings of this study vitamin D can be administered as a new immunomodulatory therapy in patients with ITP.http://ijrabms.umsu.ac.ir/article-1-96-en.pdfimmune thrombocytopenia (itp)vitamin diran
spellingShingle Mahsa Matinkia
Rahim Asghari
Hamdollah Sharifi
Low serum vitamin D levels in Iranians with immune thrombocytopenia: A single-center study
Journal of Research in Applied and Basic Medical Sciences
immune thrombocytopenia (itp)
vitamin d
iran
title Low serum vitamin D levels in Iranians with immune thrombocytopenia: A single-center study
title_full Low serum vitamin D levels in Iranians with immune thrombocytopenia: A single-center study
title_fullStr Low serum vitamin D levels in Iranians with immune thrombocytopenia: A single-center study
title_full_unstemmed Low serum vitamin D levels in Iranians with immune thrombocytopenia: A single-center study
title_short Low serum vitamin D levels in Iranians with immune thrombocytopenia: A single-center study
title_sort low serum vitamin d levels in iranians with immune thrombocytopenia a single center study
topic immune thrombocytopenia (itp)
vitamin d
iran
url http://ijrabms.umsu.ac.ir/article-1-96-en.pdf
work_keys_str_mv AT mahsamatinkia lowserumvitamindlevelsiniranianswithimmunethrombocytopeniaasinglecenterstudy
AT rahimasghari lowserumvitamindlevelsiniranianswithimmunethrombocytopeniaasinglecenterstudy
AT hamdollahsharifi lowserumvitamindlevelsiniranianswithimmunethrombocytopeniaasinglecenterstudy